Trevi Therapeutics, Inc. TRVI Write Off Of Deferred Offering Costs
Write Off Of Deferred Offering Costs at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept trvi:WriteOffOfDeferredOfferingCosts.
The official record: Trevi Therapeutics, Inc.’s 10-K, filed March 17, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s write off of deferred offering costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s write off of deferred offering costs?
- Trevi Therapeutics, Inc. (TRVI) reported write off of deferred offering costs of $6.5K in Q4 2025.
- What does write off of deferred offering costs mean?
- The expense recognized when previously capitalized costs associated with a planned or aborted equity or debt offering are written off. This occurs when a financing transaction is cancelled or delayed, resulting in the immediate recognition of sunk costs. It serves as a measure of wasted capital efficiency regarding financing efforts.